Oak Associates LTD Astrazeneca PLC Transaction History

Oak Associates LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $528,352 - $603,744	-15,200 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $1.17 Million - $1.25 Million	-33,800 Reduced 68.98%	15,200 $534,000
Q1 2018 May 14, 2018	SELL	$32.97 - $36.63 $194,523 - $216,117	-5,900 Reduced 10.75%	49,000 $1.71 Million
Q4 2017 Feb 08, 2018	BUY	$32.09 - $34.78 $1.76 Million - $1.91 Million	54,900	54,900 $1.91 Million

1,343

492M

4.99M

3.18M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Oak Associates LTD , based on Form 13F filings with the SEC.

Stay updated on Oak Associates LTD with notifications on news.